Aptamers Market Size, Share & Trends Analysis By Product, By Applications, By Technology, By End Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global Aptamers Market is projected to be worth USD 592 million by 2030
According to SPER Market Research, the Aptamers Market estimated to reach USD 592 million by 2030 with a CAGR of 16.4%. Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules, which bind to a specific target molecule. They are used to facilitate discoveries in basic research, ensure food safety and environment monitoring.
Increase in the occurrence of chronic diseases, the record breaking number of clinical trials, and awareness about the pros of aptamers than antibodies, growing investment in R&D, and aptamers-based therapeutics and diagnostics; are the fuel for the growth of aptamers market.
Impact of COVID-19 on the Aptamers Market
The outbreak of COVID-19 boosted the production companies which provide aptamers -based therapeutics & diagnostics.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By product type, By Application, By Technology, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, South America and Rest of the World
Companies Covered
Aptamer Group, Aptamer Sciences, Inc. Aptagen, LLC, Raptamer Discovery Group, SomaLogic Inc.
Drivers: increasing awareness of pros of aptamers over antibodies
Aptamers can better target smaller molecules than antibody. Aptamers are used both in diagnostic & therapeutic applications. It can cross easily the BBB i.e. blood brain barrier, cost effective as compared to antibodies.
Restrains: Low market acceptance as compared to antibodies
Even though there is lots of a pro of aptamers than antibody, it has little affinity, less approval by the market, low acceptance by the scientific community. This is probable the reason for shrinkage of the market.
Opportunities: Growth in the venture capital funding for research on aptamers
Increase in the investment, increase venture capital, for both therapeutic and diagnostic applicable aptamers. This leads to the expansion of this market.
Challenges: Shortage of skilled & trained professionals
Need of trained person, highly technical, lack of personnel is the challenges to this market.
Global Aptamers Market, by Product:
Based upon product type, Aptamers market segmented as; DNA Aptamers, XNA Aptamers, RNA Aptamers.
Global Aptamers Market, by Application;
Based upon Application, Aptamers market segmented as; Therapeutics Development, Research & Development, Diagnostic, Others.
Global Aptamers Market, by Technology:
Based upon the Technology, Aptamers market segmented as; SELEX, Others.
Global Aptamers Market, by End Users:
Based upon the End Users, Aptamers market segmented as; Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs, Others
Global Aptamers Market, by End Region:
The biggest share of Aptamers Market is with North America. This is due to the existence of top market players, accessibility of funds for innovative techniques.
According to SPER Market Research, the Aptamers Market estimated to reach USD 592 million by 2030 with a CAGR of 16.4%. Aptamers are short, single-stranded DNA, RNA, or synthetic XNA molecules, which bind to a specific target molecule. They are used to facilitate discoveries in basic research, ensure food safety and environment monitoring.
Increase in the occurrence of chronic diseases, the record breaking number of clinical trials, and awareness about the pros of aptamers than antibodies, growing investment in R&D, and aptamers-based therapeutics and diagnostics; are the fuel for the growth of aptamers market.
Impact of COVID-19 on the Aptamers Market
The outbreak of COVID-19 boosted the production companies which provide aptamers -based therapeutics & diagnostics.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By product type, By Application, By Technology, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, South America and Rest of the World
Companies Covered
Aptamer Group, Aptamer Sciences, Inc. Aptagen, LLC, Raptamer Discovery Group, SomaLogic Inc.
Drivers: increasing awareness of pros of aptamers over antibodies
Aptamers can better target smaller molecules than antibody. Aptamers are used both in diagnostic & therapeutic applications. It can cross easily the BBB i.e. blood brain barrier, cost effective as compared to antibodies.
Restrains: Low market acceptance as compared to antibodies
Even though there is lots of a pro of aptamers than antibody, it has little affinity, less approval by the market, low acceptance by the scientific community. This is probable the reason for shrinkage of the market.
Opportunities: Growth in the venture capital funding for research on aptamers
Increase in the investment, increase venture capital, for both therapeutic and diagnostic applicable aptamers. This leads to the expansion of this market.
Challenges: Shortage of skilled & trained professionals
Need of trained person, highly technical, lack of personnel is the challenges to this market.
Global Aptamers Market, by Product:
Based upon product type, Aptamers market segmented as; DNA Aptamers, XNA Aptamers, RNA Aptamers.
Global Aptamers Market, by Application;
Based upon Application, Aptamers market segmented as; Therapeutics Development, Research & Development, Diagnostic, Others.
Global Aptamers Market, by Technology:
Based upon the Technology, Aptamers market segmented as; SELEX, Others.
Global Aptamers Market, by End Users:
Based upon the End Users, Aptamers market segmented as; Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs, Others
Global Aptamers Market, by End Region:
The biggest share of Aptamers Market is with North America. This is due to the existence of top market players, accessibility of funds for innovative techniques.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Aptamers Market
4.4. Market Trends
5. GLOBAL APTAMERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
5.1. DNA Aptamers
5.2. XNA Aptamers
5.3. RNA Aptamers
6. GLOBAL APTAMERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Therapeutics Development
6.2. Research & Development
6.3. Diagnostic
6.4. Others
7. GLOBAL APTAMERS MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
7.1. SELEX
7.2. Others
8. GLOBAL APTAMERS MARKET, BY END USERS, 2019-2030 (USD MILLION)
8.1. Pharmaceutical & Biotechnology Companies
8.2. Academic & Government Research Institutes
8.3. CROs
8.4. Others
8.5. Global Aptamers Market, by End Users, 2019-2030 (USD Million)
9. GLOBAL APTAMERS MARKET, BY END REGION, 2019-2030 (USD MILLION)
9.1. North America
9.2. Europe
9.3. APAC
9.4. Latin America
9.5. Middle East
9.6. Africa
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Market Share Analysis, By Key Players
10.3. Competitive Scenario
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments
11. COMPANY PROFILES
11.1. Aptagen, LLC
11.2. Aptamer Group
11.3. Aptamer Sciences, Inc.
11.4. Raptamer Discovery Group
11.5. SomaLogic Inc.
12. APPENDIX
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Aptamers Market
4.4. Market Trends
5. GLOBAL APTAMERS MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
5.1. DNA Aptamers
5.2. XNA Aptamers
5.3. RNA Aptamers
6. GLOBAL APTAMERS MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Therapeutics Development
6.2. Research & Development
6.3. Diagnostic
6.4. Others
7. GLOBAL APTAMERS MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
7.1. SELEX
7.2. Others
8. GLOBAL APTAMERS MARKET, BY END USERS, 2019-2030 (USD MILLION)
8.1. Pharmaceutical & Biotechnology Companies
8.2. Academic & Government Research Institutes
8.3. CROs
8.4. Others
8.5. Global Aptamers Market, by End Users, 2019-2030 (USD Million)
9. GLOBAL APTAMERS MARKET, BY END REGION, 2019-2030 (USD MILLION)
9.1. North America
9.2. Europe
9.3. APAC
9.4. Latin America
9.5. Middle East
9.6. Africa
10. COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Market Share Analysis, By Key Players
10.3. Competitive Scenario
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments
11. COMPANY PROFILES
11.1. Aptagen, LLC
11.2. Aptamer Group
11.3. Aptamer Sciences, Inc.
11.4. Raptamer Discovery Group
11.5. SomaLogic Inc.
12. APPENDIX
